RxElite, Inc. is proud to announce that they have appointed Rick Schindewolf Senior Vice President for business development. Formerly a Vice President with Cardinal Health, Mr. Schindewolf played an essential part in the building of the international business development program for blow-fill-seal and sterile product sales. RxElite, a developer, manufacturer, and marketer of specialty generic prescription drug products, has high hopes for the future with the addition of Mr. Schindewolf to their company.
“I am charging Rick Schindewolf with developing our business opportunities that result from our acquisition of FineTech in Israel. I am very optimistic in the progress we are making, as we implement our business strategy and vision as the generic prescription drug manufacturer of choice,” commented Jonathan Houssian, the CEO and founder of RxElite. “I am confident that Rick is the right person to capitalize on several strategic opportunities we identified to sell our products, while maintaining excellent profit margins. Additionally, Rick will complement Dr. Arie L. Gutman and our new research and development operations in Israel.”
Mr. Schindewolf brings a vast amount of experience with him that spans over twenty years in the pharmaceutical and medical device industries. The last ten years were spent at Cardinal Health, where he was active in the manufacturing business that recently spun off as Catalent Pharma Solutions. Having held senior level positions at Cardinal/Catalent within the sterile products business in finance, general management, new product rollouts, and business development, he was also involved in several key business and product acquisitions.
RxElite, Inc. engages in the development, manufacturing, and marketing of generic prescription drug products in specialty generic markets. Some of their products are; anesthesia gases, sterile liquid dose products, sterile unit dose inhalation respiratory products, injectable drugs, and trans-dermal patch products. Hospitals and hospital group purchasing organizations are RxElite’s primary customers, along with national and regional wholesalers, direct pharmacy stocking chains, homecare companies, and outpatient and ambulatory care clinics. It has partnerships with Stason Pharmaceuticals, Inc.; Alkem Laboratories Limited; Core Tech Solutions, Inc.; and Zach Systems S.P.A.
Let us hear your thoughts below: